Diagnostic performance of Mindray CL1200i high sensitivity cardiac troponin I assay compared to Abbott Alinity cardiac troponin I assay for the diagnosis of type 1 and 2 acute myocardial infarction in females and males: MERITnI study
The Mindray CL1200i hs-cTnI assay provides the relevant clinical diagnostic information to enable clinicians to deliver cost-effective care for patients to aid in the diagnosis of MI predicated on 0- and 2-h serial testing based on sex-specific 99th percentiles. Novel observations were observed for findings based on different URLs and for females and MI types.
Authors
- Karen Schulz (ORCID: https://orcid.org/0000-0002-5268-8711)
- Stephen W. Smith (ORCID: https://orcid.org/0000-0002-9166-9804)
- Yader B. Sandoval (ORCID: https://orcid.org/0000-0003-4800-2972)
- katie meyer
- Barrett Wagner (ORCID: https://orcid.org/0000-0002-5336-8285)
- Fred S. Apple (ORCID: https://orcid.org/0000-0002-5920-6498)
- Kevin Buda (ORCID: https://orcid.org/0000-0003-3465-5681)
- Anne Sexter
- Hannah M. Brown (ORCID: https://orcid.org/0000-0001-6342-3316)
- Alanna Ladd
- Kathryn Worrell
Institutions
- University of Minnesota (US)
- Abbott Northwestern Hospital (US)
- Minneapolis Heart Institute Foundation (US)
- Hennepin Healthcare Research Institute (US)
Publication Details
- Journal
- Clinical Chemistry and Laboratory Medicine (CCLM)
- Published
- 2025-02-07
- DOI
- https://doi.org/10.1515/cclm-2024-1373
- Citations
- 1
- Primary Topic
- Acute Myocardial Infarction Research
- Type
- article
- Field-Weighted Citation Impact
- 1.39